Related Experiment Videos
Association of long-COVID with major adverse cardiovascular events and mortality: a real-world data cohort study
Yueh-Ting Tsai1,2,3, Bo-Yuan Wang2,3, Sai-Wai Ho2,3
1Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Insights
Long COVID significantly increases the risk of major adverse cardiovascular events (MACE) and all-cause mortality. This study highlights the critical need for cardiovascular monitoring in long COVID patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Limited research exists on the cardiovascular impact of long COVID.
- Understanding long COVID's association with major adverse cardiovascular events (MACE) and mortality is crucial.
Purpose of the Study:
- To investigate the association between long COVID and the risk of MACE.
- To examine the link between long COVID and all-cause mortality.
Main Methods:
- Retrospective cohort study using TriNetX real-world data (2020-2023).
- Included adult patients diagnosed with COVID-19.
- Compared long COVID patients (diagnosed 3-6 months post-COVID) with non-long COVID patients.
Main Results:
- Long COVID patients had a 4.48 times higher risk of MACE (HR: 4.48, 95% CI: 3.95-5.07).
- Elevated risks observed for coronary artery disease (HR: 6.48) and stroke (HR: 3.46).
- Mortality risk was 1.53 times higher in the long COVID group (HR: 1.53, 95% CI: 1.38-1.69).
Conclusions:
- Long COVID is associated with a significantly increased risk of MACE.
- Patients with long COVID face higher risks for cardiovascular events and mortality.
Background:
There is a limited body of research examining the association between long COVID and major adverse cardiovascular events (MACE) as well as all-cause mortality. This study aimed to investigate the association between long COVID and both MACE and mortality.
Methods:
This retrospective cohort study utilized multicenter real-world data from the TriNetX research network platform, which contains electronic health records from multiple healthcare organizations. Patients aged 18 years and older who were diagnosed with COVID-19 between 2020 and 2023 were included. The exposure group comprised individuals diagnosed with long-COVID within 3 to 6 months after their initial COVID-19 diagnosis, while the comparison group included COVID-19 patients without a diagnosis of long-COVID. The primary outcomes were the risk of major adverse cardiovascular events (MACE) and all-cause mortality. Follow-up commenced 90 days after the index date and continued until the occurrence of the study outcome or the date of the last available medical record.
Results:
The risk of MACE was markedly higher in the long-COVID cohort compared to the non-long-COVID cohort. The overall hazard ratio (HR) for MACE was 4.48 (95% CI: 3.95-5.07). Specific conditions such as coronary artery disease and stroke exhibited particularly high HRs, at 6.48 (5.29-7.95) and 3.46 (2.96-4.04) respectively. Mortality was significantly higher in the long-COVID group, with an HR of 1.53 (1.38-1.69).
Conclusions:
Compared to patients without long COVID, patients with long COVID had a higher risk of developing MACE.
Related Concept Videos
Longitudinal Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations